The Scoop cover image

Vibe Bio CEO explains how this DAO plans to revolutionize the trillion dollar pharmaceutical industry

The Scoop

00:00

Rare Disease Block - What's Your Execution Plan?

The challenge with drug development in the rare ease space is not finding a candidate treatment, it's funding it. Despite affecting one in ten americans, this disease space is actually somewhat cost effective and lower cost compared to other disease areas. So for verly modest dollars, several ons, venten 15 million dollars, you could potentially get a medicine through a clinical trial and potentially approved. And ouknow, as you noted, we were fortune nough to raise 12 million dollars in our first run of financing. That was led by initialized capital ere working with parl sing there their health care partner,. mike dutis from six man ventures and formerly of the block also participated

Play episode from 28:59
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app